SCHEMBL7250340

SCHEMBL7250340

CCC(C)(C)C(=O)C(=O)N1CC[C@H]1C(=O)OC

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 18/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2004442 0.91 FKBP1A (0.92) FKBP1A
SCHEMBL15048988 0.91 FKBP1A (0.92) FKBP1A
SCHEMBL4679960 0.90 FKBP1A (1.00) FKBP1A
SCHEMBL1776165 0.90 FKBP1A (1.00) FKBP1A
SCHEMBL6317432 0.83 FKBP1A (0.57) FKBP1A
SCHEMBL12311519 0.79 FKBP1A (0.72) FKBP1A
SCHEMBL8587480 0.78 FKBP1A (0.80) FKBP1A
SCHEMBL499268 0.78 FKBP1A (0.80) FKBP1A
SCHEMBL6534225 0.78 FKBP1A (0.60) FKBP1A
SCHEMBL10066851 0.78 FKBP1A (0.92) FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6544976-B1 Treating disorders characterized by neuronal damage caused by disease or trauma, such as Parkinson's disease, Alzheimer's disease, stroke, multiple sclerosis, amyotrophic lateral sclerosis, diabetic neuropathy and Bell's palsy. ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-04-08 US disclosed
WO-2001004091-A1 NEUROTROPHIC 2-AZETIDINECARBOXYLIC ACID DERIVATIVES, AND RELATED COMPOSITIONS AND METHODS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-01-18 WO disclosed